Nearly 3 in 10 Medicare Part D beneficiaries (29 percent) received opioids in 2018, a significant decrease from the previous 2 years. At the same time, the number of beneficiaries receiving drugs for medication-assisted treatment (MAT) for opioid use disorder has steadily increased and reached 174,000 in 2018. In addition, the number of beneficiaries receiving prescriptions through Part D for naloxone—a drug that can reverse the effects of an opioid overdose—more than doubled from 2017 to 2018.
Source: U.S. Department of Health and Human Services, Office of Inspector General
Read more at: https://oig.hhs.gov/oei/reports/oei-02-19-00390.pdf